JP2011501958A - ブタＤＣ−ＳＩＧＮ、ＩＣＡＭ−３およびＬＳＥＣｔｉｎならびにそれらの使用 - Google Patents
ブタＤＣ−ＳＩＧＮ、ＩＣＡＭ−３およびＬＳＥＣｔｉｎならびにそれらの使用 Download PDFInfo
- Publication number
- JP2011501958A JP2011501958A JP2010532042A JP2010532042A JP2011501958A JP 2011501958 A JP2011501958 A JP 2011501958A JP 2010532042 A JP2010532042 A JP 2010532042A JP 2010532042 A JP2010532042 A JP 2010532042A JP 2011501958 A JP2011501958 A JP 2011501958A
- Authority
- JP
- Japan
- Prior art keywords
- virus
- sign
- cells
- porcine
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108010037897 DC-specific ICAM-3 grabbing nonintegrin Proteins 0.000 title claims abstract description 99
- 101000766915 Homo sapiens C-type lectin domain family 4 member G Proteins 0.000 title abstract description 152
- 108010064600 Intercellular Adhesion Molecule-3 Proteins 0.000 title abstract description 103
- 102100028666 C-type lectin domain family 4 member G Human genes 0.000 title abstract description 101
- 102100037871 Intercellular adhesion molecule 3 Human genes 0.000 title abstract description 90
- 210000004027 cell Anatomy 0.000 claims abstract description 445
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 267
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 142
- 238000000034 method Methods 0.000 claims abstract description 107
- 239000002299 complementary DNA Substances 0.000 claims abstract description 98
- 241000700605 Viruses Species 0.000 claims abstract description 97
- 241000282414 Homo sapiens Species 0.000 claims abstract description 86
- 210000004443 dendritic cell Anatomy 0.000 claims abstract description 86
- 210000001616 monocyte Anatomy 0.000 claims abstract description 73
- 239000002773 nucleotide Substances 0.000 claims abstract description 64
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 64
- 238000010367 cloning Methods 0.000 claims abstract description 37
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 29
- 230000000295 complement effect Effects 0.000 claims abstract description 26
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 26
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 26
- 108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 12
- 230000001902 propagating effect Effects 0.000 claims abstract description 5
- 241001135989 Porcine reproductive and respiratory syndrome virus Species 0.000 claims description 109
- 230000014509 gene expression Effects 0.000 claims description 103
- 239000000047 product Substances 0.000 claims description 54
- 210000005220 cytoplasmic tail Anatomy 0.000 claims description 46
- 208000015181 infectious disease Diseases 0.000 claims description 40
- 239000000427 antigen Substances 0.000 claims description 39
- 108091007433 antigens Proteins 0.000 claims description 39
- 102000036639 antigens Human genes 0.000 claims description 39
- 239000013598 vector Substances 0.000 claims description 36
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 33
- 239000012634 fragment Substances 0.000 claims description 31
- 210000002540 macrophage Anatomy 0.000 claims description 30
- 239000003446 ligand Substances 0.000 claims description 29
- 238000003757 reverse transcription PCR Methods 0.000 claims description 28
- 241001465754 Metazoa Species 0.000 claims description 27
- 241000282898 Sus scrofa Species 0.000 claims description 27
- 101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 claims description 25
- 102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 claims description 25
- 150000001720 carbohydrates Chemical class 0.000 claims description 23
- 108020001507 fusion proteins Proteins 0.000 claims description 23
- 102000037865 fusion proteins Human genes 0.000 claims description 23
- 241000725303 Human immunodeficiency virus Species 0.000 claims description 21
- 241000288906 Primates Species 0.000 claims description 21
- 241000315672 SARS coronavirus Species 0.000 claims description 21
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 21
- 238000012163 sequencing technique Methods 0.000 claims description 20
- 230000002458 infectious effect Effects 0.000 claims description 17
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 claims description 15
- 230000003321 amplification Effects 0.000 claims description 15
- 239000008280 blood Substances 0.000 claims description 15
- 239000001963 growth medium Substances 0.000 claims description 15
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 15
- 241001115402 Ebolavirus Species 0.000 claims description 14
- 210000004369 blood Anatomy 0.000 claims description 14
- 210000004698 lymphocyte Anatomy 0.000 claims description 14
- 229920001542 oligosaccharide Polymers 0.000 claims description 14
- 238000001890 transfection Methods 0.000 claims description 13
- 102100021992 CD209 antigen Human genes 0.000 claims description 12
- 241000711549 Hepacivirus C Species 0.000 claims description 12
- 241000526636 Nipah henipavirus Species 0.000 claims description 12
- 241000713311 Simian immunodeficiency virus Species 0.000 claims description 12
- 230000003612 virological effect Effects 0.000 claims description 12
- 230000036039 immunity Effects 0.000 claims description 11
- 150000002482 oligosaccharides Chemical class 0.000 claims description 11
- 241000725619 Dengue virus Species 0.000 claims description 10
- 241001115401 Marburgvirus Species 0.000 claims description 10
- 210000002845 virion Anatomy 0.000 claims description 10
- 241000701024 Human betaherpesvirus 5 Species 0.000 claims description 9
- 210000001185 bone marrow Anatomy 0.000 claims description 9
- 230000000120 cytopathologic effect Effects 0.000 claims description 9
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 8
- 241000710777 Classical swine fever virus Species 0.000 claims description 8
- 241000710803 Equine arteritis virus Species 0.000 claims description 8
- 208000005577 Gastroenteritis Diseases 0.000 claims description 8
- 241000710842 Japanese encephalitis virus Species 0.000 claims description 8
- 241001135549 Porcine epidemic diarrhea virus Species 0.000 claims description 8
- 241000156302 Porcine hemagglutinating encephalomyelitis virus Species 0.000 claims description 8
- 241000711493 Porcine respiratory coronavirus Species 0.000 claims description 8
- 241000710960 Sindbis virus Species 0.000 claims description 8
- 241000725681 Swine influenza virus Species 0.000 claims description 8
- 241000710886 West Nile virus Species 0.000 claims description 8
- 230000003834 intracellular effect Effects 0.000 claims description 8
- 210000000952 spleen Anatomy 0.000 claims description 8
- 241000710780 Bovine viral diarrhea virus 1 Species 0.000 claims description 7
- 241000710945 Eastern equine encephalitis virus Species 0.000 claims description 7
- 241000725579 Feline coronavirus Species 0.000 claims description 7
- 241000724675 Hepatitis E virus Species 0.000 claims description 7
- 241000712431 Influenza A virus Species 0.000 claims description 7
- 241000713196 Influenza B virus Species 0.000 claims description 7
- 241000713297 Influenza C virus Species 0.000 claims description 7
- 241000881705 Porcine endogenous retrovirus Species 0.000 claims description 7
- 241000711798 Rabies lyssavirus Species 0.000 claims description 7
- 241000700584 Simplexvirus Species 0.000 claims description 7
- 241000701093 Suid alphaherpesvirus 1 Species 0.000 claims description 7
- 241001485053 Suid betaherpesvirus 2 Species 0.000 claims description 7
- 241000700565 Swinepox virus Species 0.000 claims description 7
- 241000711975 Vesicular stomatitis virus Species 0.000 claims description 7
- 108091036078 conserved sequence Proteins 0.000 claims description 7
- 230000007812 deficiency Effects 0.000 claims description 7
- 210000004408 hybridoma Anatomy 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 244000309711 non-enveloped viruses Species 0.000 claims description 7
- 241001673669 Porcine circovirus 2 Species 0.000 claims description 6
- 238000010899 nucleation Methods 0.000 claims description 5
- 239000013603 viral vector Substances 0.000 claims description 5
- 101710156618 Peptide deformylase 1 Proteins 0.000 claims description 4
- 239000007795 chemical reaction product Substances 0.000 claims description 4
- 238000012258 culturing Methods 0.000 claims description 4
- 230000002934 lysing effect Effects 0.000 claims description 3
- 235000016709 nutrition Nutrition 0.000 claims description 3
- 210000005259 peripheral blood Anatomy 0.000 claims description 2
- 239000011886 peripheral blood Substances 0.000 claims description 2
- 101000897416 Homo sapiens CD209 antigen Proteins 0.000 claims 10
- 241000282324 Felis Species 0.000 claims 6
- 241000893570 Hendra henipavirus Species 0.000 claims 6
- 102100034343 Integrase Human genes 0.000 claims 3
- 239000013600 plasmid vector Substances 0.000 claims 2
- 210000003527 eukaryotic cell Anatomy 0.000 claims 1
- 210000001236 prokaryotic cell Anatomy 0.000 claims 1
- 108010029485 Protein Isoforms Proteins 0.000 abstract description 49
- 102000001708 Protein Isoforms Human genes 0.000 abstract description 49
- 238000012512 characterization method Methods 0.000 abstract description 21
- 230000012743 protein tagging Effects 0.000 abstract description 3
- 230000001976 improved effect Effects 0.000 abstract description 2
- 235000018102 proteins Nutrition 0.000 description 112
- 239000013615 primer Substances 0.000 description 78
- 108700024394 Exon Proteins 0.000 description 69
- 230000027455 binding Effects 0.000 description 65
- 101000749311 Homo sapiens C-type lectin domain family 4 member M Proteins 0.000 description 58
- 102100040843 C-type lectin domain family 4 member M Human genes 0.000 description 52
- 108020004999 messenger RNA Proteins 0.000 description 46
- 241000283690 Bos taurus Species 0.000 description 39
- 102000056354 human CLEC4G Human genes 0.000 description 35
- 102000005962 receptors Human genes 0.000 description 35
- 108020003175 receptors Proteins 0.000 description 35
- 230000003993 interaction Effects 0.000 description 30
- 210000001165 lymph node Anatomy 0.000 description 30
- 241000282887 Suidae Species 0.000 description 28
- 210000004185 liver Anatomy 0.000 description 27
- 102000004196 processed proteins & peptides Human genes 0.000 description 27
- 244000052769 pathogen Species 0.000 description 26
- 102000003930 C-Type Lectins Human genes 0.000 description 25
- 108090000342 C-Type Lectins Proteins 0.000 description 25
- 101000599862 Homo sapiens Intercellular adhesion molecule 3 Proteins 0.000 description 25
- 238000000338 in vitro Methods 0.000 description 25
- 102100037872 Intercellular adhesion molecule 2 Human genes 0.000 description 24
- 241000699666 Mus <mouse, genus> Species 0.000 description 23
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 23
- 239000002953 phosphate buffered saline Substances 0.000 description 23
- 229920001184 polypeptide Polymers 0.000 description 22
- 241000894007 species Species 0.000 description 22
- 210000001519 tissue Anatomy 0.000 description 22
- 108700026244 Open Reading Frames Proteins 0.000 description 21
- 210000005105 peripheral blood lymphocyte Anatomy 0.000 description 21
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 20
- 108020004414 DNA Proteins 0.000 description 20
- 241000283073 Equus caballus Species 0.000 description 19
- 235000014633 carbohydrates Nutrition 0.000 description 19
- 239000002679 microRNA Substances 0.000 description 19
- 238000010186 staining Methods 0.000 description 19
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 18
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 18
- 108091026890 Coding region Proteins 0.000 description 17
- 108010064593 Intercellular Adhesion Molecule-1 Proteins 0.000 description 17
- 102100037877 Intercellular adhesion molecule 1 Human genes 0.000 description 17
- 108020005067 RNA Splice Sites Proteins 0.000 description 17
- 210000001744 T-lymphocyte Anatomy 0.000 description 17
- 238000012217 deletion Methods 0.000 description 17
- 230000037430 deletion Effects 0.000 description 17
- 210000002889 endothelial cell Anatomy 0.000 description 17
- 230000028993 immune response Effects 0.000 description 17
- 239000002523 lectin Substances 0.000 description 17
- 241000282465 Canis Species 0.000 description 16
- 241000713772 Human immunodeficiency virus 1 Species 0.000 description 16
- 230000002441 reversible effect Effects 0.000 description 16
- 108020004485 Nonsense Codon Proteins 0.000 description 15
- 108091008109 Pseudogenes Proteins 0.000 description 15
- 102000057361 Pseudogenes Human genes 0.000 description 15
- 230000002788 anti-peptide Effects 0.000 description 15
- 239000011575 calcium Substances 0.000 description 15
- 230000001419 dependent effect Effects 0.000 description 15
- 238000001514 detection method Methods 0.000 description 15
- 238000002474 experimental method Methods 0.000 description 15
- 239000012091 fetal bovine serum Substances 0.000 description 15
- 230000035772 mutation Effects 0.000 description 15
- 102000016289 Cell Adhesion Molecules Human genes 0.000 description 14
- 108010067225 Cell Adhesion Molecules Proteins 0.000 description 14
- 210000001132 alveolar macrophage Anatomy 0.000 description 14
- 150000001413 amino acids Chemical class 0.000 description 14
- 239000000203 mixture Substances 0.000 description 14
- 239000013612 plasmid Substances 0.000 description 14
- 101710148794 Intercellular adhesion molecule 2 Proteins 0.000 description 13
- 230000006870 function Effects 0.000 description 13
- 230000001404 mediated effect Effects 0.000 description 13
- 230000001717 pathogenic effect Effects 0.000 description 13
- 102100034349 Integrase Human genes 0.000 description 12
- 108091092195 Intron Proteins 0.000 description 12
- 108010064548 Lymphocyte Function-Associated Antigen-1 Proteins 0.000 description 12
- 235000001014 amino acid Nutrition 0.000 description 12
- 229940024606 amino acid Drugs 0.000 description 12
- 238000004458 analytical method Methods 0.000 description 12
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 12
- 230000037434 nonsense mutation Effects 0.000 description 12
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 11
- 102000003886 Glycoproteins Human genes 0.000 description 11
- 108090000288 Glycoproteins Proteins 0.000 description 11
- 241000282412 Homo Species 0.000 description 11
- 101000599858 Homo sapiens Intercellular adhesion molecule 2 Proteins 0.000 description 11
- 108700011259 MicroRNAs Proteins 0.000 description 11
- 241000282577 Pan troglodytes Species 0.000 description 11
- 230000004927 fusion Effects 0.000 description 11
- 230000008569 process Effects 0.000 description 11
- 229960005486 vaccine Drugs 0.000 description 11
- 101000599861 Bos taurus Intercellular adhesion molecule 3 Proteins 0.000 description 10
- 241000282560 Macaca mulatta Species 0.000 description 10
- 238000012300 Sequence Analysis Methods 0.000 description 10
- 238000003556 assay Methods 0.000 description 10
- 238000010790 dilution Methods 0.000 description 10
- 239000012895 dilution Substances 0.000 description 10
- 238000009826 distribution Methods 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 238000000684 flow cytometry Methods 0.000 description 10
- 238000003364 immunohistochemistry Methods 0.000 description 10
- 230000007246 mechanism Effects 0.000 description 10
- 230000010076 replication Effects 0.000 description 10
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 9
- 241000283707 Capra Species 0.000 description 9
- 241000289427 Didelphidae Species 0.000 description 9
- 239000003242 anti bacterial agent Substances 0.000 description 9
- 229940088710 antibiotic agent Drugs 0.000 description 9
- 230000005540 biological transmission Effects 0.000 description 9
- 229910052791 calcium Inorganic materials 0.000 description 9
- BRZYSWJRSDMWLG-CAXSIQPQSA-N geneticin Natural products O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](C(C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-CAXSIQPQSA-N 0.000 description 9
- 239000013067 intermediate product Substances 0.000 description 9
- 210000003734 kidney Anatomy 0.000 description 9
- 108091070501 miRNA Proteins 0.000 description 9
- 230000036961 partial effect Effects 0.000 description 9
- 230000037361 pathway Effects 0.000 description 9
- 101000878605 Homo sapiens Low affinity immunoglobulin epsilon Fc receptor Proteins 0.000 description 8
- 102100038007 Low affinity immunoglobulin epsilon Fc receptor Human genes 0.000 description 8
- 108091081024 Start codon Proteins 0.000 description 8
- 101710090322 Truncated surface protein Proteins 0.000 description 8
- 230000008901 benefit Effects 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 8
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 8
- 230000002163 immunogen Effects 0.000 description 8
- 210000005228 liver tissue Anatomy 0.000 description 8
- 210000004072 lung Anatomy 0.000 description 8
- 230000008488 polyadenylation Effects 0.000 description 8
- 108010038196 saccharide-binding proteins Proteins 0.000 description 8
- 241000282472 Canis lupus familiaris Species 0.000 description 7
- 102000004856 Lectins Human genes 0.000 description 7
- 108090001090 Lectins Proteins 0.000 description 7
- 241000699670 Mus sp. Species 0.000 description 7
- 230000004988 N-glycosylation Effects 0.000 description 7
- 241000289371 Ornithorhynchus anatinus Species 0.000 description 7
- 108010076504 Protein Sorting Signals Proteins 0.000 description 7
- 108091005956 Type II transmembrane proteins Proteins 0.000 description 7
- 210000000612 antigen-presenting cell Anatomy 0.000 description 7
- 230000010261 cell growth Effects 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 238000011161 development Methods 0.000 description 7
- 238000001727 in vivo Methods 0.000 description 7
- 210000000265 leukocyte Anatomy 0.000 description 7
- 238000002826 magnetic-activated cell sorting Methods 0.000 description 7
- 239000012528 membrane Substances 0.000 description 7
- 238000013081 phylogenetic analysis Methods 0.000 description 7
- 238000012545 processing Methods 0.000 description 7
- 108020005345 3' Untranslated Regions Proteins 0.000 description 6
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 6
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 6
- 102000012750 Membrane Glycoproteins Human genes 0.000 description 6
- 108010090054 Membrane Glycoproteins Proteins 0.000 description 6
- 238000009004 PCR Kit Methods 0.000 description 6
- 241001494479 Pecora Species 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- 239000005090 green fluorescent protein Substances 0.000 description 6
- 238000011534 incubation Methods 0.000 description 6
- -1 mannose glycan Chemical class 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 210000004980 monocyte derived macrophage Anatomy 0.000 description 6
- 108700000180 mouse LSECtin Proteins 0.000 description 6
- 230000003169 placental effect Effects 0.000 description 6
- 210000001541 thymus gland Anatomy 0.000 description 6
- 238000011144 upstream manufacturing Methods 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 102000014914 Carrier Proteins Human genes 0.000 description 5
- 108020004705 Codon Proteins 0.000 description 5
- 102000004127 Cytokines Human genes 0.000 description 5
- 108090000695 Cytokines Proteins 0.000 description 5
- 108091092724 Noncoding DNA Proteins 0.000 description 5
- 241000700159 Rattus Species 0.000 description 5
- 108010083644 Ribonucleases Proteins 0.000 description 5
- 102000006382 Ribonucleases Human genes 0.000 description 5
- 230000004913 activation Effects 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 5
- 230000012202 endocytosis Effects 0.000 description 5
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 5
- 239000013604 expression vector Substances 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 230000006698 induction Effects 0.000 description 5
- 238000003780 insertion Methods 0.000 description 5
- 230000037431 insertion Effects 0.000 description 5
- 239000000543 intermediate Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 5
- 102000007863 pattern recognition receptors Human genes 0.000 description 5
- 108010089193 pattern recognition receptors Proteins 0.000 description 5
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 5
- 102100026197 C-type lectin domain family 2 member D Human genes 0.000 description 4
- 108020004635 Complementary DNA Proteins 0.000 description 4
- 241000711573 Coronaviridae Species 0.000 description 4
- 102000007260 Deoxyribonuclease I Human genes 0.000 description 4
- 108010008532 Deoxyribonuclease I Proteins 0.000 description 4
- 241000283086 Equidae Species 0.000 description 4
- 241000713800 Feline immunodeficiency virus Species 0.000 description 4
- 101000912615 Homo sapiens C-type lectin domain family 2 member D Proteins 0.000 description 4
- 239000012097 Lipofectamine 2000 Substances 0.000 description 4
- 229920000057 Mannan Polymers 0.000 description 4
- 108091027974 Mature messenger RNA Proteins 0.000 description 4
- 241001529936 Murinae Species 0.000 description 4
- 101000599857 Mus musculus Intercellular adhesion molecule 1 Proteins 0.000 description 4
- 238000012408 PCR amplification Methods 0.000 description 4
- 238000011530 RNeasy Mini Kit Methods 0.000 description 4
- 241000283984 Rodentia Species 0.000 description 4
- 108010029176 Sialic Acid Binding Ig-like Lectin 1 Proteins 0.000 description 4
- 102100032855 Sialoadhesin Human genes 0.000 description 4
- 230000005867 T cell response Effects 0.000 description 4
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 4
- 108091008324 binding proteins Proteins 0.000 description 4
- 239000013611 chromosomal DNA Substances 0.000 description 4
- 238000010276 construction Methods 0.000 description 4
- 238000004925 denaturation Methods 0.000 description 4
- 230000036425 denaturation Effects 0.000 description 4
- 210000001198 duodenum Anatomy 0.000 description 4
- 239000003623 enhancer Substances 0.000 description 4
- 230000037433 frameshift Effects 0.000 description 4
- 108091008053 gene clusters Proteins 0.000 description 4
- 210000002216 heart Anatomy 0.000 description 4
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 4
- 210000000987 immune system Anatomy 0.000 description 4
- 230000003053 immunization Effects 0.000 description 4
- 238000010166 immunofluorescence Methods 0.000 description 4
- 238000013388 immunohistochemistry analysis Methods 0.000 description 4
- 210000001985 kidney epithelial cell Anatomy 0.000 description 4
- 230000000670 limiting effect Effects 0.000 description 4
- 244000144972 livestock Species 0.000 description 4
- 230000004807 localization Effects 0.000 description 4
- 239000012188 paraffin wax Substances 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- 238000000159 protein binding assay Methods 0.000 description 4
- 230000003252 repetitive effect Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 4
- 210000002027 skeletal muscle Anatomy 0.000 description 4
- 230000008685 targeting Effects 0.000 description 4
- 230000002123 temporal effect Effects 0.000 description 4
- 238000004448 titration Methods 0.000 description 4
- 230000032258 transport Effects 0.000 description 4
- 238000001262 western blot Methods 0.000 description 4
- 238000002689 xenotransplantation Methods 0.000 description 4
- 208000030507 AIDS Diseases 0.000 description 3
- 241000282693 Cercopithecidae Species 0.000 description 3
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 229920001917 Ficoll Polymers 0.000 description 3
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 3
- 102000039966 ICAM family Human genes 0.000 description 3
- 108091069108 ICAM family Proteins 0.000 description 3
- 101150040790 ICAM3 gene Proteins 0.000 description 3
- 108060003951 Immunoglobulin Proteins 0.000 description 3
- 102100037874 Intercellular adhesion molecule 4 Human genes 0.000 description 3
- 108020004684 Internal Ribosome Entry Sites Proteins 0.000 description 3
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 3
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 3
- 108010052285 Membrane Proteins Proteins 0.000 description 3
- 241001467552 Mycobacterium bovis BCG Species 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 241000282579 Pan Species 0.000 description 3
- 229940096437 Protein S Drugs 0.000 description 3
- 238000002123 RNA extraction Methods 0.000 description 3
- 101710198474 Spike protein Proteins 0.000 description 3
- 102000002689 Toll-like receptor Human genes 0.000 description 3
- 108020000411 Toll-like receptor Proteins 0.000 description 3
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 3
- 108010003533 Viral Envelope Proteins Proteins 0.000 description 3
- 230000001464 adherent effect Effects 0.000 description 3
- 238000003277 amino acid sequence analysis Methods 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 229960002685 biotin Drugs 0.000 description 3
- 239000011616 biotin Substances 0.000 description 3
- 229940098773 bovine serum albumin Drugs 0.000 description 3
- 230000017455 cell-cell adhesion Effects 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 125000000151 cysteine group Chemical class N[C@@H](CS)C(=O)* 0.000 description 3
- 229930182830 galactose Natural products 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 102000050442 human CLEC4M Human genes 0.000 description 3
- 210000003917 human chromosome Anatomy 0.000 description 3
- 230000001900 immune effect Effects 0.000 description 3
- 238000002649 immunization Methods 0.000 description 3
- 102000018358 immunoglobulin Human genes 0.000 description 3
- 230000002757 inflammatory effect Effects 0.000 description 3
- 210000003292 kidney cell Anatomy 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 210000005229 liver cell Anatomy 0.000 description 3
- 210000005210 lymphoid organ Anatomy 0.000 description 3
- 125000000311 mannosyl group Chemical group C1([C@@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 238000010369 molecular cloning Methods 0.000 description 3
- 210000004877 mucosa Anatomy 0.000 description 3
- 238000002887 multiple sequence alignment Methods 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 238000002703 mutagenesis Methods 0.000 description 3
- 231100000350 mutagenesis Toxicity 0.000 description 3
- 210000000066 myeloid cell Anatomy 0.000 description 3
- 230000008520 organization Effects 0.000 description 3
- 101150078841 pan gene Proteins 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000002062 proliferating effect Effects 0.000 description 3
- 230000000644 propagated effect Effects 0.000 description 3
- 230000000284 resting effect Effects 0.000 description 3
- 238000002864 sequence alignment Methods 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 230000009897 systematic effect Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000013519 translation Methods 0.000 description 3
- 239000003656 tris buffered saline Substances 0.000 description 3
- 239000004474 valine Substances 0.000 description 3
- 230000007501 viral attachment Effects 0.000 description 3
- 241000606748 Actinobacillus pleuropneumoniae Species 0.000 description 2
- 108090001008 Avidin Proteins 0.000 description 2
- 108050009406 C-type lectin-like Proteins 0.000 description 2
- 101710126509 CD209 antigen Proteins 0.000 description 2
- 102000005701 Calcium-Binding Proteins Human genes 0.000 description 2
- 108010045403 Calcium-Binding Proteins Proteins 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 108091035707 Consensus sequence Proteins 0.000 description 2
- 201000011001 Ebola Hemorrhagic Fever Diseases 0.000 description 2
- 241000710188 Encephalomyocarditis virus Species 0.000 description 2
- 108700039887 Essential Genes Proteins 0.000 description 2
- 241000711950 Filoviridae Species 0.000 description 2
- 238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- CBOVGULVQSVMPT-CIUDSAMLSA-N Glu-Pro-Asn Chemical group [H]N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(O)=O CBOVGULVQSVMPT-CIUDSAMLSA-N 0.000 description 2
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 2
- 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 2
- 208000031886 HIV Infections Diseases 0.000 description 2
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 2
- 229920002971 Heparan sulfate Polymers 0.000 description 2
- 108010073141 Hepatitis C virus glycoprotein E2 Proteins 0.000 description 2
- 101000935040 Homo sapiens Integrin beta-2 Proteins 0.000 description 2
- 101000599852 Homo sapiens Intercellular adhesion molecule 1 Proteins 0.000 description 2
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 2
- 102100025390 Integrin beta-2 Human genes 0.000 description 2
- 101710148793 Intercellular adhesion molecule 4 Proteins 0.000 description 2
- 102000004388 Interleukin-4 Human genes 0.000 description 2
- 108090000978 Interleukin-4 Proteins 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 102000018697 Membrane Proteins Human genes 0.000 description 2
- 206010027476 Metastases Diseases 0.000 description 2
- 102000018656 Mitogen Receptors Human genes 0.000 description 2
- 108010052006 Mitogen Receptors Proteins 0.000 description 2
- 241000186359 Mycobacterium Species 0.000 description 2
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 2
- OVRNDRQMDRJTHS-RTRLPJTCSA-N N-acetyl-D-glucosamine Chemical group CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-RTRLPJTCSA-N 0.000 description 2
- 239000012124 Opti-MEM Substances 0.000 description 2
- 239000002033 PVDF binder Substances 0.000 description 2
- 241000723990 Papaya ringspot virus Species 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 206010035226 Plasma cell myeloma Diseases 0.000 description 2
- 108091081062 Repeated sequence (DNA) Proteins 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- 101710167605 Spike glycoprotein Proteins 0.000 description 2
- 108010090804 Streptavidin Proteins 0.000 description 2
- 108091036066 Three prime untranslated region Proteins 0.000 description 2
- 108070000030 Viral receptors Proteins 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 125000000539 amino acid group Chemical group 0.000 description 2
- 229940126575 aminoglycoside Drugs 0.000 description 2
- 238000012197 amplification kit Methods 0.000 description 2
- 230000000890 antigenic effect Effects 0.000 description 2
- 229960000190 bacillus calmette–guérin vaccine Drugs 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 230000021164 cell adhesion Effects 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 230000002759 chromosomal effect Effects 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- 210000000805 cytoplasm Anatomy 0.000 description 2
- 230000001086 cytosolic effect Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 150000002016 disaccharides Chemical class 0.000 description 2
- 210000003038 endothelium Anatomy 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 239000013613 expression plasmid Substances 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 239000012997 ficoll-paque Substances 0.000 description 2
- PGBHMTALBVVCIT-VCIWKGPPSA-N framycetin Chemical compound N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CN)O2)N)O[C@@H]1CO PGBHMTALBVVCIT-VCIWKGPPSA-N 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 239000012737 fresh medium Substances 0.000 description 2
- 230000004547 gene signature Effects 0.000 description 2
- 238000012268 genome sequencing Methods 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000013595 glycosylation Effects 0.000 description 2
- 238000006206 glycosylation reaction Methods 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 230000016784 immunoglobulin production Effects 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 230000015788 innate immune response Effects 0.000 description 2
- 108010044426 integrins Proteins 0.000 description 2
- 102000006495 integrins Human genes 0.000 description 2
- 229940028885 interleukin-4 Drugs 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 210000001365 lymphatic vessel Anatomy 0.000 description 2
- 239000006166 lysate Substances 0.000 description 2
- 238000013507 mapping Methods 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 102000027540 membrane-bound PRRs Human genes 0.000 description 2
- 108091008872 membrane-bound PRRs Proteins 0.000 description 2
- 230000009401 metastasis Effects 0.000 description 2
- 108091056360 miR-350 stem-loop Proteins 0.000 description 2
- 108091061985 miR-350-1 stem-loop Proteins 0.000 description 2
- 108091086625 miR-350-2 stem-loop Proteins 0.000 description 2
- 239000011325 microbead Substances 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 239000007758 minimum essential medium Substances 0.000 description 2
- 230000004001 molecular interaction Effects 0.000 description 2
- 230000000877 morphologic effect Effects 0.000 description 2
- 201000000050 myeloid neoplasm Diseases 0.000 description 2
- 229940053050 neomycin sulfate Drugs 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 230000026731 phosphorylation Effects 0.000 description 2
- 238000006366 phosphorylation reaction Methods 0.000 description 2
- 230000004962 physiological condition Effects 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 108091033319 polynucleotide Proteins 0.000 description 2
- 102000040430 polynucleotide Human genes 0.000 description 2
- 239000002157 polynucleotide Substances 0.000 description 2
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 238000011165 process development Methods 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 239000002516 radical scavenger Substances 0.000 description 2
- 230000014891 regulation of alternative nuclear mRNA splicing, via spliceosome Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000003362 replicative effect Effects 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 102000014452 scavenger receptors Human genes 0.000 description 2
- 108010078070 scavenger receptors Proteins 0.000 description 2
- 210000005212 secondary lymphoid organ Anatomy 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 208000010648 susceptibility to HIV infection Diseases 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000003146 transient transfection Methods 0.000 description 2
- 238000002255 vaccination Methods 0.000 description 2
- 230000005570 vertical transmission Effects 0.000 description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- ODWNBAWYDSWOAF-UHFFFAOYSA-N 2,4,4-trimethylpentan-2-yloxybenzene Chemical compound CC(C)(C)CC(C)(C)OC1=CC=CC=C1 ODWNBAWYDSWOAF-UHFFFAOYSA-N 0.000 description 1
- WONRDHPFOHAWOG-UHFFFAOYSA-N 2-chloronaphthalen-1-ol Chemical compound C1=CC=C2C(O)=C(Cl)C=CC2=C1 WONRDHPFOHAWOG-UHFFFAOYSA-N 0.000 description 1
- 108091093088 Amplicon Proteins 0.000 description 1
- 241001292006 Arteriviridae Species 0.000 description 1
- 208000007467 Arterivirus Infections Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 208000032116 Autoimmune Experimental Encephalomyelitis Diseases 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 241000304886 Bacilli Species 0.000 description 1
- 241000606125 Bacteroides Species 0.000 description 1
- 206010057361 Blood brain barrier defect Diseases 0.000 description 1
- 241000588779 Bordetella bronchiseptica Species 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 108091078235 Canis familiaris miR-350 stem-loop Proteins 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- 102100024046 Cell adhesion molecule 3 Human genes 0.000 description 1
- 101710197433 Cell adhesion molecule 3 Proteins 0.000 description 1
- 102000019034 Chemokines Human genes 0.000 description 1
- 108010012236 Chemokines Proteins 0.000 description 1
- 208000006332 Choriocarcinoma Diseases 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108090000909 Collectins Proteins 0.000 description 1
- 102000004405 Collectins Human genes 0.000 description 1
- 102100032768 Complement receptor type 2 Human genes 0.000 description 1
- 108010060123 Conjugate Vaccines Proteins 0.000 description 1
- 102100031673 Corneodesmosin Human genes 0.000 description 1
- 101710139375 Corneodesmosin Proteins 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 239000004971 Cross linker Substances 0.000 description 1
- 241001559589 Cullen Species 0.000 description 1
- 241000701022 Cytomegalovirus Species 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 206010012310 Dengue fever Diseases 0.000 description 1
- 241000710829 Dengue virus group Species 0.000 description 1
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000710781 Flaviviridae Species 0.000 description 1
- 101150034914 GP2a gene Proteins 0.000 description 1
- 101000834253 Gallus gallus Actin, cytoplasmic 1 Proteins 0.000 description 1
- 241000606807 Glaesserella parasuis Species 0.000 description 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Natural products NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 101710114810 Glycoprotein Proteins 0.000 description 1
- 102000005744 Glycoside Hydrolases Human genes 0.000 description 1
- 108010031186 Glycoside Hydrolases Proteins 0.000 description 1
- 208000037357 HIV infectious disease Diseases 0.000 description 1
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 1
- 241000700721 Hepatitis B virus Species 0.000 description 1
- 208000037319 Hepatitis infectious Diseases 0.000 description 1
- 241000700586 Herpesviridae Species 0.000 description 1
- 241001272567 Hominoidea Species 0.000 description 1
- 101000941929 Homo sapiens Complement receptor type 2 Proteins 0.000 description 1
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 1
- 101001046686 Homo sapiens Integrin alpha-M Proteins 0.000 description 1
- 101000599868 Homo sapiens Intercellular adhesion molecule 4 Proteins 0.000 description 1
- 101000632467 Homo sapiens Pulmonary surfactant-associated protein D Proteins 0.000 description 1
- 101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 description 1
- 102000003839 Human Proteins Human genes 0.000 description 1
- 108090000144 Human Proteins Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 108010042653 IgA receptor Proteins 0.000 description 1
- 108010073816 IgE Receptors Proteins 0.000 description 1
- 102000009438 IgE Receptors Human genes 0.000 description 1
- 108700005091 Immunoglobulin Genes Proteins 0.000 description 1
- 206010062016 Immunosuppression Diseases 0.000 description 1
- 102100022338 Integrin alpha-M Human genes 0.000 description 1
- 102100022337 Integrin alpha-V Human genes 0.000 description 1
- 102100039919 Intercellular adhesion molecule 5 Human genes 0.000 description 1
- 101710148796 Intercellular adhesion molecule 5 Proteins 0.000 description 1
- 102000002227 Interferon Type I Human genes 0.000 description 1
- 108010014726 Interferon Type I Proteins 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 241000194036 Lactococcus Species 0.000 description 1
- 241000589902 Leptospira Species 0.000 description 1
- 241000282561 Macaca nemestrina Species 0.000 description 1
- 108010068997 Mannose-Binding Lectins Proteins 0.000 description 1
- 102000001698 Mannose-Binding Lectins Human genes 0.000 description 1
- 108010061593 Member 14 Tumor Necrosis Factor Receptors Proteins 0.000 description 1
- 108091030146 MiRBase Proteins 0.000 description 1
- 108091028684 Mir-145 Proteins 0.000 description 1
- 101000761989 Mus musculus CD209 antigen-like protein A Proteins 0.000 description 1
- 101100452013 Mus musculus Icam1 gene Proteins 0.000 description 1
- 101000599865 Mus musculus Intercellular adhesion molecule 4 Proteins 0.000 description 1
- 241000186366 Mycobacterium bovis Species 0.000 description 1
- 241000204045 Mycoplasma hyopneumoniae Species 0.000 description 1
- 241001553014 Myrsine salicina Species 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- SPEFJYZGXZENAF-UHFFFAOYSA-N N-cyclohexyl-1-(2,4-dichlorophenyl)-6-methyl-4H-indeno[1,2-c]pyrazole-3-carboxamide Chemical compound C=1C(C)=CC=C(C2=3)C=1CC=3C(C(=O)NC1CCCCC1)=NN2C1=CC=C(Cl)C=C1Cl SPEFJYZGXZENAF-UHFFFAOYSA-N 0.000 description 1
- 102100023064 Nectin-1 Human genes 0.000 description 1
- 101710043845 Nectin-1 Proteins 0.000 description 1
- 108090000189 Neuropeptides Proteins 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 241000606860 Pasteurella Species 0.000 description 1
- 241000606856 Pasteurella multocida Species 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 108010089814 Plant Lectins Proteins 0.000 description 1
- 102100029740 Poliovirus receptor Human genes 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 208000005342 Porcine Reproductive and Respiratory Syndrome Diseases 0.000 description 1
- 102000003923 Protein Kinase C Human genes 0.000 description 1
- 108090000315 Protein Kinase C Proteins 0.000 description 1
- 241000125945 Protoparvovirus Species 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 101000599859 Rattus norvegicus Intercellular adhesion molecule 1 Proteins 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 241000712907 Retroviridae Species 0.000 description 1
- 241000702670 Rotavirus Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241001138501 Salmonella enterica Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 108010047827 Sialic Acid Binding Immunoglobulin-like Lectins Proteins 0.000 description 1
- 102000007073 Sialic Acid Binding Immunoglobulin-like Lectins Human genes 0.000 description 1
- 101710150766 Sialic acid-binding lectin Proteins 0.000 description 1
- 101900350318 Simian immunodeficiency virus Surface protein gp120 Proteins 0.000 description 1
- 108020004459 Small interfering RNA Proteins 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000194021 Streptococcus suis Species 0.000 description 1
- 102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 description 1
- 241000710924 Togaviridae Species 0.000 description 1
- 102100023935 Transmembrane glycoprotein NMB Human genes 0.000 description 1
- 241000711484 Transmissible gastroenteritis virus Species 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 102100028785 Tumor necrosis factor receptor superfamily member 14 Human genes 0.000 description 1
- 108091023045 Untranslated Region Proteins 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 108020000999 Viral RNA Proteins 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 108010048673 Vitronectin Receptors Proteins 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000004721 adaptive immunity Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000001261 affinity purification Methods 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000000961 alloantigen Effects 0.000 description 1
- VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000030741 antigen processing and presentation Effects 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008436 biogenesis Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 210000002798 bone marrow cell Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 238000012511 carbohydrate analysis Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000005056 cell body Anatomy 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 230000012292 cell migration Effects 0.000 description 1
- 239000013553 cell monolayer Substances 0.000 description 1
- 230000008614 cellular interaction Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 229940031670 conjugate vaccine Drugs 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 210000001787 dendrite Anatomy 0.000 description 1
- 208000025729 dengue disease Diseases 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 241001493065 dsRNA viruses Species 0.000 description 1
- 210000003162 effector t lymphocyte Anatomy 0.000 description 1
- 230000026502 entry into host cell Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 208000012997 experimental autoimmune encephalomyelitis Diseases 0.000 description 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000009688 glial response Effects 0.000 description 1
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
- 230000005745 host immune response Effects 0.000 description 1
- 102000058166 human ICAM3 Human genes 0.000 description 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 229940127121 immunoconjugate Drugs 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 238000012744 immunostaining Methods 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 238000009169 immunotherapy Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000002608 insulinlike Effects 0.000 description 1
- 229940047122 interleukins Drugs 0.000 description 1
- 210000003535 interstitial dendritic cell Anatomy 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000001865 kupffer cell Anatomy 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 125000001909 leucine group Chemical group [H]N(*)C(C(*)=O)C([H])([H])C(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000000670 ligand binding assay Methods 0.000 description 1
- 230000007762 localization of cell Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000005073 lymphatic endothelial cell Anatomy 0.000 description 1
- 210000003563 lymphoid tissue Anatomy 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000005541 medical transmission Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000002941 microtiter virus yield reduction assay Methods 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 230000004660 morphological change Effects 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 238000007857 nested PCR Methods 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 238000011587 new zealand white rabbit Methods 0.000 description 1
- 108091027963 non-coding RNA Proteins 0.000 description 1
- 102000042567 non-coding RNA Human genes 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229940051027 pasteurella multocida Drugs 0.000 description 1
- 229940056360 penicillin g Drugs 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 102000013415 peroxidase activity proteins Human genes 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- PHEDXBVPIONUQT-RGYGYFBISA-N phorbol 13-acetate 12-myristate Chemical compound C([C@]1(O)C(=O)C(C)=C[C@H]1[C@@]1(O)[C@H](C)[C@H]2OC(=O)CCCCCCCCCCCCC)C(CO)=C[C@H]1[C@H]1[C@]2(OC(C)=O)C1(C)C PHEDXBVPIONUQT-RGYGYFBISA-N 0.000 description 1
- 239000002644 phorbol ester Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000003726 plant lectin Substances 0.000 description 1
- 108010048507 poliovirus receptor Proteins 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000004850 protein–protein interaction Effects 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 208000017443 reproductive system disease Diseases 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 238000007423 screening assay Methods 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 210000004989 spleen cell Anatomy 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000000225 synapse Anatomy 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000010474 transient expression Effects 0.000 description 1
- 108091007466 transmembrane glycoproteins Proteins 0.000 description 1
- 102000027257 transmembrane receptors Human genes 0.000 description 1
- 108091008578 transmembrane receptors Proteins 0.000 description 1
- 230000014599 transmission of virus Effects 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
- 230000007502 viral entry Effects 0.000 description 1
- 230000008478 viral entry into host cell Effects 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000009447 viral pathogenesis Effects 0.000 description 1
- 229960004854 viral vaccine Drugs 0.000 description 1
- 230000024058 virion binding Effects 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70525—ICAM molecules, e.g. CD50, CD54, CD102
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/7056—Lectin superfamily, e.g. CD23, CD72
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80007P | 2007-10-29 | 2007-10-29 | |
| PCT/US2008/012251 WO2009058285A2 (en) | 2007-10-29 | 2008-10-29 | PORCINE DC-SIGN, ICAM-3 AND LSECtin AND USES THEREOF |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011501958A true JP2011501958A (ja) | 2011-01-20 |
| JP2011501958A5 JP2011501958A5 (https=) | 2011-12-15 |
Family
ID=40591693
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010532042A Pending JP2011501958A (ja) | 2007-10-29 | 2008-10-29 | ブタＤＣ−ＳＩＧＮ、ＩＣＡＭ−３およびＬＳＥＣｔｉｎならびにそれらの使用 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US8415118B2 (https=) |
| EP (2) | EP2662384A1 (https=) |
| JP (1) | JP2011501958A (https=) |
| KR (1) | KR20100087344A (https=) |
| CN (1) | CN102066415A (https=) |
| AU (1) | AU2008319384A1 (https=) |
| BR (1) | BRPI0818477A2 (https=) |
| CA (1) | CA2704207A1 (https=) |
| CO (1) | CO6270367A2 (https=) |
| MX (1) | MX2010004548A (https=) |
| NZ (1) | NZ584893A (https=) |
| RU (1) | RU2010121862A (https=) |
| WO (1) | WO2009058285A2 (https=) |
| ZA (1) | ZA201002773B (https=) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10201503351RA (en) | 2010-01-19 | 2015-06-29 | Harvard College | Engineered Opsonin for Pathogen Detection and Treatment |
| AU2012284097B2 (en) | 2011-07-18 | 2017-08-03 | President And Fellows Of Harvard College | Engineered microbe-targeting molecules and uses thereof |
| EP2798069B1 (en) | 2011-12-15 | 2017-03-29 | Washington University | Porcine knob xenotype chimeric adenoviral vector for dendritic cell infection |
| WO2013130875A1 (en) | 2012-02-29 | 2013-09-06 | President And Fellows Of Harvard College | Rapid antibiotic susceptibility testing |
| CA2862516C (en) | 2012-03-27 | 2023-02-14 | Ngm Biopharmaceuticals, Inc. | Compositions and methods of use for treating metabolic disorders |
| WO2014144325A1 (en) | 2013-03-15 | 2014-09-18 | President And Fellows Of Harvard College | Methods and compositions for improving detection and/or capture of a target entity |
| JP6649250B2 (ja) | 2013-05-21 | 2020-02-19 | プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ | 操作されたヘム結合性構成物およびその使用 |
| US10513546B2 (en) | 2013-12-18 | 2019-12-24 | President And Fellows Of Harvard College | CRP capture/detection of gram positive bacteria |
| AU2015296640B2 (en) * | 2014-07-30 | 2020-05-21 | Ngm Biopharmaceuticals, Inc. | Compositions and methods of use for treating metabolic disorders |
| US9616114B1 (en) | 2014-09-18 | 2017-04-11 | David Gordon Bermudes | Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity |
| EP3701969A1 (en) | 2014-10-31 | 2020-09-02 | NGM Biopharmaceuticals, Inc. | Compositions and methods of use for treating metabolic disorders |
| CN104749361B (zh) * | 2015-01-21 | 2017-04-19 | 中国农业科学院哈尔滨兽医研究所 | 猪圆环病毒2型抗原捕获elisa试剂盒 |
| CN105445457B (zh) * | 2015-03-24 | 2017-08-11 | 中国农业科学院哈尔滨兽医研究所 | 检测猪圆环病毒2型Cap蛋白的单克隆抗体及试剂盒 |
| US10676723B2 (en) | 2015-05-11 | 2020-06-09 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| EP3331549B1 (en) | 2015-08-06 | 2020-12-23 | President and Fellows of Harvard College | Improved microbe-binding molecules and uses thereof |
| US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
| CN106957847A (zh) * | 2017-05-16 | 2017-07-18 | 吉林大学 | 有效抑制仔猪流行性腹泻病毒的siRNA及用途 |
| CN107488635A (zh) * | 2017-09-22 | 2017-12-19 | 中国人民解放军第三军医大学第三附属医院 | 单克隆细胞及其制备方法和用途 |
| CN108893474B (zh) * | 2018-02-07 | 2021-11-16 | 电子科技大学 | 草鱼细胞间粘附分子基因的分离和鉴定 |
| CN108977444A (zh) * | 2018-06-28 | 2018-12-11 | 西南大学 | 沉默荣昌猪CD14表达的siRNA及筛选方法与应用 |
| CN109679952B (zh) * | 2018-12-24 | 2022-04-15 | 西北农林科技大学 | 一种抗PRRSV感染的猪源miR-c89及其应用 |
| CN109652384B (zh) * | 2019-02-21 | 2021-10-26 | 昆明理工大学 | 一种体外培养戊型肝炎病毒的方法 |
| CN109836478B (zh) * | 2019-03-19 | 2022-06-14 | 扬州大学 | 非洲猪瘟病毒p11.5蛋白特异性多克隆抗体的制备方法及应用 |
| CN109943536B (zh) * | 2019-03-26 | 2021-09-14 | 昆明理工大学 | 一种戊型肝炎病毒的培养方法及其灭活疫苗的制备方法 |
| CN111575409B (zh) * | 2020-05-23 | 2023-04-18 | 黑龙江八一农垦大学 | 基于整合素配体识别肽抑制猪流行性腹泻病毒感染的研究方法 |
| WO2022050476A1 (ko) * | 2020-09-04 | 2022-03-10 | 이형우 | 인간 면역결핍 바이러스 감염 또는 감염 질환의 치료용 조성물 |
| CN115725656B (zh) * | 2021-09-01 | 2026-01-16 | 联邦生物科技(珠海横琴)有限公司 | 一种以细胞质rna病毒为载体递送干扰rna的方法 |
| CN121454060A (zh) * | 2026-01-05 | 2026-02-03 | 江苏立维斯德生物技术有限公司 | 一种基于免疫荧光法检测轮状病毒的方法、试剂盒及其用途 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07509599A (ja) * | 1992-06-11 | 1995-10-26 | ニューヨーク ユニバーシティー | キメラ受容体ポリペプチド，ヒトｈ１３タンパク質，ならびにその使用 |
| JP2002543762A (ja) * | 1999-03-25 | 2002-12-24 | ブリストル−マイヤーズ スクイブ カンパニー | ヒトｃｌａｘタンパク質およびその可溶性融合タンパク質をコードするｄｎａ分子 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9409768D0 (en) | 1994-05-16 | 1994-07-06 | Medical Res Council | Trimerising polypeptides |
| US6146873A (en) | 1994-11-10 | 2000-11-14 | Baxter Aktiengesellschaft | Production of orthomyxoviruses in monkey kidney cells using protein-free media |
| US6280953B1 (en) | 1998-01-30 | 2001-08-28 | Evolutionary Genomics, L.L.C. | Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions |
| CN1355690A (zh) | 1999-04-16 | 2002-06-26 | 奥赛尔股份有限公司 | 一种延长可溶性病毒特异性配体在粘膜上半寿期的方法 |
| EP1046651A1 (en) | 1999-04-19 | 2000-10-25 | Koninklijke Universiteit Nijmegen | Composition and method for modulating dendritic cell-T interaction |
| US6391567B1 (en) | 2000-03-02 | 2002-05-21 | New York University | Identifying compounds inhibiting DC-sign facilitation of HIV into cells |
| GB0318247D0 (en) * | 2003-08-05 | 2003-09-10 | Royal Veterinary College | Antigen delivery system |
| CA2563432A1 (en) | 2004-04-16 | 2005-12-01 | Genentech, Inc. | Method for augmenting b cell depletion |
-
2008
- 2008-10-29 RU RU2010121862/10A patent/RU2010121862A/ru not_active Application Discontinuation
- 2008-10-29 WO PCT/US2008/012251 patent/WO2009058285A2/en not_active Ceased
- 2008-10-29 KR KR1020107011603A patent/KR20100087344A/ko not_active Withdrawn
- 2008-10-29 JP JP2010532042A patent/JP2011501958A/ja active Pending
- 2008-10-29 MX MX2010004548A patent/MX2010004548A/es active IP Right Grant
- 2008-10-29 US US12/739,744 patent/US8415118B2/en not_active Expired - Fee Related
- 2008-10-29 AU AU2008319384A patent/AU2008319384A1/en not_active Abandoned
- 2008-10-29 BR BRPI0818477 patent/BRPI0818477A2/pt not_active IP Right Cessation
- 2008-10-29 NZ NZ584893A patent/NZ584893A/xx not_active IP Right Cessation
- 2008-10-29 CA CA2704207A patent/CA2704207A1/en not_active Abandoned
- 2008-10-29 EP EP13179857.1A patent/EP2662384A1/en not_active Withdrawn
- 2008-10-29 EP EP08844649A patent/EP2207798A2/en not_active Withdrawn
- 2008-10-29 CN CN2008801240560A patent/CN102066415A/zh active Pending
-
2010
- 2010-04-20 ZA ZA2010/02773A patent/ZA201002773B/en unknown
- 2010-04-29 CO CO10050942A patent/CO6270367A2/es not_active Application Discontinuation
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07509599A (ja) * | 1992-06-11 | 1995-10-26 | ニューヨーク ユニバーシティー | キメラ受容体ポリペプチド，ヒトｈ１３タンパク質，ならびにその使用 |
| JP2002543762A (ja) * | 1999-03-25 | 2002-12-24 | ブリストル−マイヤーズ スクイブ カンパニー | ヒトｃｌａｘタンパク質およびその可溶性融合タンパク質をコードするｄｎａ分子 |
Non-Patent Citations (15)
| Title |
|---|
| JPN6013031838; ＨＵＡＮＧ， Ｙ．Ｗ． ｅｔ ａｌ．: Ｄｅｖ． Ｃｏｍｐ． Ｉｍｍｕｎｏｌ． , 20081023, ｐｐ．４６４-４８０ * |
| JPN6013031839; ＴＥＵＮＩＳ， Ｂ． ｅｔ ａｌ．: Ｊ． Ｂｉｏｌ． Ｃｈｅｍ． Ｖｏｌ．２７７, 2002, ｐｐ．１１３１４-１１３２０ * |
| JPN6013031840; ＬＥＥＢ， Ｔ． ａｎｄ ＭＵＬＬＥＲ， Ｍ．: Ｇｅｎｅ Ｖｏｌ．３４３, 2004, ｐｐ．２３９-２４４ * |
| JPN6013031841; ＰＡＲＫ， Ｃ．Ｇ． ｅｔ ａｌ．: Ｉｎｔ． Ｉｍｍｕｎｏｌ． Ｖｏｌ．１３， Ｎｏ．１０, 2001, ｐｐ．１２８３-１２９０ * |
| JPN6013031843; ＰＯＷＬＥＳＬＡＮＤ， Ａ．Ｓ． ｅｔ ａｌ．: Ｊ． Ｂｉｏｌ． Ｃｈｅｍ． Ｖｏｌ．２８３, 20071105, ｐｐ．５９３-６０２ * |
| JPN6013031845; ＬＯＶＩＮＧ， Ｃ．Ｌ． ｅｔ ａｌ．: Ｉｍｍｕｎｏｌｏｇｙ Ｖｏｌ．１２０, 2006, ｐｐ．２１７-２２９ * |
| JPN6013031847; ＢＯＷＤＥＮ， Ｔ．Ａ． ｅｔ ａｌ．: Ｊ． Ｖｉｒｏｌ． Ｖｏｌ．８２，Ｎｏ．２３, 20080924, ｐｐ．１１６２８-１１６３６ * |
| JPN6013031849; ＵＥＮＩＳＨＩ， Ｈ．: '"ＣＪ００７７７７ ｆｕｌｌ-ｌｅｎｇｔｈ ｅｎｒｉｃｈｅｄ ｓｗｉｎｅ ｃＤＮＡ ｌｉｂｒａｒｙ， ａｄｕｌｔ ｍｅｓｅｎｔｅｒｉｃ ｌｙｍｐｈ ｎｏｄｅ Ｓｕｓ ｓｃｒｏｆａ ｃＤＮＡ ｃｌｏｎｅ' ＧｅｎＢａｎｋ Ａｃｃｅｓｓｉｏｎ ｎｏ． ＣＪ００７７７７ * |
| JPN6013031851; ＬＥＥＢ， Ｔ．: '"Ｓｕｓ ｓｃｒｏｆａ ｐａｒｔｉａｌ ＩＣＡＭ３ ｇｅｎｅ， ＴＹＫ２， ＣＤＣ３７， ＰＤＥ４Ａ， ＫＥＡＰ１， ＥＤＧ８ ａｎｄ ＡＰＧ４Ｄ ｇｅｎｅｓ ａｎｄ ｐａｒｔｉａｌ ＦＬＪ１２９４９' ＧｅｎＢａｎｋ Ａｃｃｅｓｓｉｏｎ ｎｏ． ＡＪ６３２３０３ , 20061115 * |
| JPN6013031853; ＢＡＳＨＩＲＯＶＡ， Ａ．Ａ． ｅｔ ａｌ．: Ｊ． Ｖｉｒｏｌ． Ｖｏｌ．７７， Ｎｏ．１, 2003, ｐｐ．２１７-２２７ * |
| JPN6013031855; ＢＡＲＩＢＡＵＤ， Ｆ． ｅｔ ａｌ．: Ｊ． Ｖｉｒｏｌ． Ｖｏｌ．７５， Ｎｏ．２１, 2001, ｐｐ．１０２８１-１０２８９ * |
| JPN6013031857; ＬＩＵ， Ｗ． ｅｔ ａｌ．: Ｊ． Ｂｉｏｌ． Ｃｈｅｍ． Ｖｏｌ．２７９， Ｎｏ．１８, 2004, ｐｐ．１８７４８-１８７５８ * |
| JPN6013031859; ＰＡＩＬＬＯＴ， Ｒ． ｅｔ ａｌ．: Ｉｍｍｕｎｏｌｏｇｙ Ｖｏｌ．１０２, 2001, ｐｐ．３９６-４０４ * |
| JPN6013031860; ＲＥＥＶＥＳ， Ｊ．Ｄ． ｅｔ ａｌ．: Ｊ． Ｇｅｎ． Ｖｉｒｏｌ． Ｖｏｌ．７９, 1998, ｐｐ．１７９３-１７９９ * |
| JPN6013031862; ＫＡＲＬＳＳＯＮ， Ｉ． ｅｔ ａｌ．: ＡＩＤＳ Ｖｏｌ．１７, 2003, ｐｐ．２５６１-２５６９ * |
Also Published As
| Publication number | Publication date |
|---|---|
| KR20100087344A (ko) | 2010-08-04 |
| BRPI0818477A2 (pt) | 2015-04-14 |
| US20100317054A1 (en) | 2010-12-16 |
| US8415118B2 (en) | 2013-04-09 |
| EP2207798A2 (en) | 2010-07-21 |
| WO2009058285A9 (en) | 2009-07-09 |
| CN102066415A (zh) | 2011-05-18 |
| NZ584893A (en) | 2012-08-31 |
| AU2008319384A1 (en) | 2009-05-07 |
| WO2009058285A2 (en) | 2009-05-07 |
| EP2662384A1 (en) | 2013-11-13 |
| WO2009058285A3 (en) | 2009-12-10 |
| CO6270367A2 (es) | 2011-04-20 |
| ZA201002773B (en) | 2011-10-26 |
| RU2010121862A (ru) | 2011-12-10 |
| CA2704207A1 (en) | 2009-05-07 |
| MX2010004548A (es) | 2010-05-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8415118B2 (en) | Porcine DC-SIGN, ICAM-3 and LSECtin and uses thereof | |
| Huang et al. | Porcine DC-SIGN: molecular cloning, gene structure, tissue distribution and binding characteristics | |
| EP3735983A1 (en) | Chimeric antigen receptor specific for tumor cells comprising an antigen binding domain specific for tspan8 | |
| CN115916833B (zh) | 靶向b7h3的抗原结合多肽及其应用 | |
| JP2011206060A (ja) | 可変性リンパ球受容体、その関連ポリペプチドおよび核酸、ならびにその使用 | |
| BR112019017008A2 (pt) | anticorpo, ácido nucleico, vetor de expressão, célula hospedeira, imunoconjugado multifuncional, receptor de antígeno quimérico, vírus, célula imune modificada pelo receptor do antígeno quimérico, composição farmacêutica, kit, e, uso do anticorpo. | |
| TW202342550A (zh) | 靶向ｂｃｍａ和ｇｐｒｃ５ｄ的嵌合抗原受體及其應用 | |
| US20230210902A1 (en) | Sars-cov-2-specific t cells | |
| WO2023274385A1 (zh) | 靶向her2的通用型car-t细胞及其制备方法 | |
| IL294960A (en) | Delivery of sialidase to cancer cells, immune cells and the tumor microenvironment | |
| NO341211B1 (no) | In vitro fremgangsmåte for å fremme infeksjon i en virveldyrcelle med PRRSV og en fremgangsmåte for å måle tilbøyeligheten en testcellelinje har for å tillate PRRSV-infeksjon | |
| CN118056008A (zh) | 病毒载体生产系统 | |
| AU2013204023A1 (en) | PORCINE DC-SIGN, ICAM AND LSECtin AND USES THEREOF | |
| WO2021232050A1 (en) | Natural killer cell immunotherapy for the treatment or prevention of sars-cov-2 infection | |
| AU2020391178A1 (en) | Immune cell delivery of sialidase to cancer cells, immune cells and the tumor microenvironment | |
| CN120112650A (zh) | 慢病毒配制品 | |
| JP2024527537A (ja) | Ｇｄ２を標的とするユニバーサルｃａｒ－ｔ細胞及びその製造方法並びに使用 | |
| JP2024527539A (ja) | ＩＬ１３Ｒα２を標的としたユニバーサルＣＡＲ－Ｔ細胞及びその製造方法と使用 | |
| JP2025525439A (ja) | 操作されたナチュラルキラー（ｎｋ）細胞と抗体療法との組み合わせおよび関連する方法 | |
| WO2023274386A1 (zh) | 靶向egfr的通用型car-t细胞及其制备方法 | |
| HK1157797A (en) | Porcine dc-sign, icam-3 and lsectin and uses thereof | |
| KR20250054790A (ko) | 키메라 항원 수용체 도메인 | |
| HK40087387B (zh) | 靶向b7h3的抗原结合多肽及其应用 | |
| HK40087387A (zh) | 靶向b7h3的抗原结合多肽及其应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20111027 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20111027 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130702 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20131126 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20140120 |